UNSPSC 51332818: Oxyridazine

This classification denotes a phenothiazine with the molecular formula C21H26N2OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OCW5XQQ13I, chemically known as 10h-phenothiazine, 2-methoxy-10-(2-(1-methyl-2-piperidyl)ethyl)- but generally known as oxyridazine, which bears US NIH Compound Identifier 65612. European Medicines Agency schedules Oxyridazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09577MIG.

UNSPSC 51332818 Oxyridazine, a Commodity code, describes pharmaceutical products that state and local governments procure for community health, emergency response, and pharmacy benefit programs — though recent opportunities show oxyridazine itself is rarely solicited by name; instead, jurisdictions are acquiring naloxone, generic multi-source pharmaceuticals, OTC products, and direct-to-manufacturer prescription fulfillment capabilities through competitive bidding and cooperative purchasing vehicles. The issuing bodies span county health departments, state health and human services agencies, and multistate cooperative purchasing alliances, indicating activity across public health, emergency medical services, and Medicaid pharmacy benefit administration.

Recent solicitations include Seminole County, Florida's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually (response deadline July 26, 2023), the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic pharmaceuticals and OTC products through authorized wholesalers with a response deadline of March 26, 2026, and the Texas Health and Human Services Commission's RFI on direct-to-manufacturer prescription programs (response deadline April 3, 2026). Activity concentrates in the South and Midwest, with Florida and Texas showing recent engagement and Minnesota coordinating multistate cooperative purchasing covering Oregon and other participating jurisdictions. The code sees mixed procurement models — fixed-price competitive bidding for discrete quantities, cooperative-purchasing RFPs establishing statewide or multistate vendor panels with volume-based pricing, and exploratory RFIs gathering vendor capability data before formal solicitation. Vendors face compliance requirements including cGMP certification, DSCSA compliance, E-Verify eligibility confirmation, insurance minimums ($2 million to $5 million), and performance penalties for reporting delays or onboarding failures.